• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Sana Biotechnology Reports Q3 2024 Financial Results & Updates

    GLOBENEWSWIRE

    Sana strips back cancer, CNS programs while warning of layoff

    FIERCE BIOTECH

    Sana Biotech Increases Focus on T1D & Autoimmune Diseases

    GLOBENEWSWIRE

    Sana Biotechnology To Present At Goldman Sachs Cell Therapy Day

    GLOBENEWSWIRE

    Sana Biotechnology to Present at September 2024 Investor Conferences

    GLOBENEWSWIRE

    Sana Biotech Appoints Dhaval Patel as Executive VP and Chief Scientific Officer

    GLOBENEWSWIRE

    Sana Biotechnology Appoints Dhaval Patel As EVP And Chief Scientific Officer

    GLOBENEWSWIRE

    Sana Biotechnology Reports Q2 2024 Results And Business Updates

    GLOBENEWSWIRE

    Sana Highlights Stem Cell Therapy Potential In Nature Biotech

    GLOBENEWSWIRE

    Sana Bio Q1 2024 Financials, Business Updates

    GLOBENEWSWIRE

    Sana Biotechnology to Present at May and June 2024 Investor Conferences

    GLOBENEWSWIRE

    Sana Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results

    PRESS RELEASE

    Sana Biotechnology to Present at the Cowen 44th Annual Health Care Conference

    GLOBENEWSWIRE

    Sana`s engineered islet cells control glucose in diabetic monkey

    FIERCE BIOTECH

    Sana Announces Publication of Preclinical Diabetes Data in Cell Stem Cell

    GLOBENEWSWIRE

    Sana Biotechnology Announces Closing of Upsized Public Offering

    GLOBENEWSWIRE

    Sana Biotechnology Announces Pricing of Upsized Public Offering

    GLOBENEWSWIRE

    Sana Biotechnology Announces Proposed Public Offering of Common Stock

    GLOBENEWSWIRE

    Sana Announces FDA Clearance of Investigational New Drug Application for SC262

    GLOBENEWSWIRE

    Sana Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference

    GLOBENEWSWIRE

    Sana Biotechnology Highlights Data Supporting Tumor Control and Immune Evasion Capabilities of Hypoimmune-Modified Allogeneic CAR T Cells

    GLOBENEWSWIRE

    Sana Biotechnology Publishes Early Clinical Data Showing that SC291

    GLOBENEWSWIRE

    Sana Biotechnology to Present at November and December 2023 Investor Conferences

    GLOBENEWSWIRE

    Uppsala University & Sana Announce Authorization for Islet Cell Treatment

    GLOBENEWSWIRE

    Sana Announces FDA Clearance of Investigational New Drug Application for SC291

    GLOBENEWSWIRE

    Sana Bio Reports Third Quarter 2023 Financial Results and Business Updates

    GLOBENEWSWIRE

    Sana Announces Presentations at American Society of Hematology Annual Meeting

    GLOBENEWSWIRE

    Sana retreats from in vivo CAR-T delivery, lays off 29% of staff

    FIERCE BIOTECH

    Sana Biotechnology Announces Increased Focus on Hypoimmune-Related Pipeline

    GLOBENEWSWIRE

    Sana lays off staff as cell therapy biotech awaits first clinical data

    ENDPTS

    Sana Biotechnology to Present at September 2023 Investor Conferences

    GLOBENEWSWIRE

    Sana Bio Reports Second Quarter 2023 Financial Results and Business Updates

    GLOBENEWSWIRE

    Sana Highlights Preclinical Data from Hypoimmune and Fusogen Platforms

    GLOBENEWSWIRE

    Sana Biotechnology to Present at June 2023 Investor Conferences

    GLOBENEWSWIRE

    Sana Biotechnology Reports 1Q 2023 FYR & Business Updates

    GLOBENEWSWIRE

    Sana Biotechnology Announces Preclinical Data Published in Nature Biotechnology

    GLOBENEWSWIRE

    Sana Biotechnology Announces the Acceptance of Six Abstracts for at the ASGCT

    GLOBENEWSWIRE

    Sana Biotechnology to Host Research & Development Day

    GLOBENEWSWIRE

    Sana Highlights Preclinical Hypoimmune Data for its Allogeneic CAR T Platform

    GLOBENEWSWIRE

    Sana Biotechnology Announces Preclinical Data Published in Nature Communications Demonstrating the Ability of its Hypoimmune Allogeneic CD19-directed CAR T Cells to Evade Immune Rejection and Produce Durable Anti-Tumor Responses

    GLOBENEWSWIRE

    Sana Biotechnology Announces Preclinical Data Published in Science Translational Medicine Showing its Hypoimmune Pancreatic Islet Cells Evaded Allogeneic and Autoimmune Rejection and Controlled Type 1 Diabetes in Preclinical Model

    GLOBENEWSWIRE

    Sana Biotechnology Announces the Appointment of Two Pioneers in Drug Discovery

    GLOBENEWSWIRE

    Sana Biotechnology Reports Fourth Quarter and Full Year 2022 Financial Results

    GLOBENEWSWIRE

    Sana Announces the Acceptance of Four Abstracts for Presentation at Meeting

    GLOBENEWSWIRE

    Sana Biotechnology to Present at the Cowen 43rd Annual Health Care Conference

    GLOBENEWSWIRE

    Sana to Present at Guggenheim Healthcare Talks 5th Annual Oncology Conference

    GLOBENEWSWIRE

    Sana Announces FDA Clearance of Investigational New Drug Application for SC291

    GLOBENEWSWIRE

    Sana Biotechnology to Present at the 41st Annual J.P. Morgan Conference

    GLOBENEWSWIRE

    Sana Biotechnology Highlights Hypoimmune Allogeneic CAR T Cell Programs

    GLOBENEWSWIRE

    Sana lays off 15%, trims pipeline to keep funding CAR-Ts

    FIERCEBIOTECH

    Sana Confirms Key Program Timelines and Announces Portfolio Prioritization

    GLOBENEWSWIRE

    Sana Biotechnology Tops BioSpace’s 2023 Best Places to Work Ranking

    GLOBENEWSWIRE

    Sana Biotechnology Announces Several Preclinical Data Presentations at the 64th

    GLOBENEWSWIRE

    Sana Biotechnology Reports Third Quarter 2022 Financial Results

    GLOBENEWSWIRE

    Sana Biotechnology to Present at September 2022 Investor Conferences

    GLOBENEWSWIRE

    Sana Biotechnology Reports Second Quarter 2022 Financial Results

    GLOBENEWSWIRE

    Sana Biotechnology Presents Data at ISSCR 2022 Annual Meeting

    GLOBENEWSWIRE

    Sana Biotech Announces Multiple PC Data Presentations at Upcoming ISSCR 2022

    GLOBENEWSWIRE

    Sana Biotech to Present at Goldman Sachs Annual Global Healthcare Conference

    GLOBENEWSWIRE

    Sana Biotechnology to develop Washington manufacturing facility saving $100M

    SEEKING ALPHA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.